BRIEF published on 10/23/2025 at 13:21, 5 months 9 days ago Biotest AG Cancels Extraordinary General Meeting Grifols S.A. Extraordinary General Meeting Legal Form Change Corporate Restructuring Biotest AG News
PRESS RELEASE published on 10/23/2025 at 13:16, 5 months 9 days ago Biotest AG: Cancellation of the extraordinary general meeting on 28 October 2025 Biotest AG cancels extraordinary general meeting scheduled for 28 October 2025 following withdrawal of convocation request by Grifols S.A Grifols S.A. Cancellation Extraordinary General Meeting Biotest AG Legal Form Change
BRIEF published on 10/09/2025 at 17:35, 5 months 23 days ago Yimmugo® de Biotest entre sur le marché américain Biotest AG Marché Américain Lancement De Yimmugo® Déficits Immunitaires Primaires Médicaments Dérivés Du Plasma
BRIEF published on 10/09/2025 at 17:35, 5 months 23 days ago Biotest's Yimmugo® Enters the U.S. Market Biotest AG U.S. Market Yimmugo® Launch Primary Immunodeficiencies Plasma-derived Medicines
PRESS RELEASE published on 10/09/2025 at 17:30, 5 months 23 days ago Biotest’s Yimmugo® launches in the United States Biotest AG launches Yimmugo®, a polyvalent human normal immunoglobulin (IVIg) for primary immunodeficiencies in the U.S., marking a significant milestone for the company's global growth strategy Biotest AG Yimmugo U.S. Launch Primary Immunodeficiencies IVIg
BRIEF published on 09/19/2025 at 15:05, 6 months 12 days ago Biotest AG Schedules Extraordinary General Meeting for Legal Form Change Grifols S.A. Extraordinary General Meeting Biotest AG Legal Form Change Partnership Limited By Shares
BRIEF published on 09/19/2025 at 15:05, 6 months 12 days ago Biotest AG organise une assemblée générale extraordinaire pour modifier sa forme juridique Assemblée Générale Extraordinaire Grifols SA Société En Commandite Par Actions Biotest AG Changement De Forme Juridique
PRESS RELEASE published on 09/19/2025 at 15:00, 6 months 12 days ago Biotest AG: Extraordinary general meeting convened at the request of Grifols S.A. Biotest AG's extraordinary general meeting convened at the request of Grifols S.A. to discuss changing legal form to a partnership limited by shares (KGaA) on 28 October 2025 Extraordinary General Meeting Biotest AG Legal Form Change Grifols Partnership Limited By Shares
BRIEF published on 08/04/2025 at 13:05, 7 months 28 days ago Biotest AG fait l'objet d'un examen pour un changement de structure juridique Grifols SA Biotest AG Droits Des Actionnaires Structure Juridique Réunion Extraordinaire
BRIEF published on 08/04/2025 at 13:05, 7 months 28 days ago Biotest AG Under Review for Legal Structure Change Grifols S.A. Shareholder Rights Biotest AG Extraordinary Meeting Legal Structure
Published on 04/02/2026 at 04:00, 1 hour 31 minutes ago MedMira Reports Second Quarter Results FY2025
Published on 04/02/2026 at 00:55, 4 hours 36 minutes ago Silver Spruce Resources Inc. Announces Close of $739,250 First Tranche of Non-Brokered Private Placement and Extension
Published on 04/02/2026 at 00:00, 5 hours 31 minutes ago Redwood AI Launches Collaborative Research Project with UBC's Brent Page Lab Focused on Alzheimer's Drug Discovery
Published on 04/01/2026 at 23:15, 6 hours 16 minutes ago Golden Minerals Reports Full Year 2025 Results
Published on 04/02/2026 at 00:52, 4 hours 39 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3H
Published on 04/01/2026 at 22:23, 7 hours 8 minutes ago EQS-Adhoc: Deutsche Börse AG: US court grants decision to plaintiffs’ group seeking turnover of assets attributed to Bank Markazi and held by Clearstream
Published on 04/01/2026 at 22:05, 7 hours 26 minutes ago Abivax publie ses rapports financiers auprès des autorités françaises et américaines de régulation des marchés financiers
Published on 04/01/2026 at 22:05, 7 hours 26 minutes ago Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
Published on 04/01/2026 at 19:16, 10 hours 14 minutes ago Mars 2026 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant
Published on 04/01/2026 at 18:15, 11 hours 16 minutes ago Accor signs a memorandum of understanding on the sale of its stake in Essendi
Published on 04/01/2026 at 18:15, 11 hours 16 minutes ago Accor a signé un protocole d’accord pour la cession de sa participation dans Essendi
Published on 04/01/2026 at 18:02, 11 hours 29 minutes ago CP MOULINVEST : TRANSFERT DU CONTRAT DE LIQUIDITE AUPRES DE TPICAP
Published on 04/01/2026 at 18:00, 11 hours 31 minutes ago Closing of acquisition of Chaplin's World operating company
